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PAUL R. DtMKE, i\ l. D.•
l-.. arly in the history of medicine, opium was found to be a reliable and potent
agent for the relief of pain. Through purification morphine has become popular a,
a potent and ,uperior analgesic agent. l\ lorphine and all of its derivatives are
effective becau',e they elevate the puin threshold, produce sleep, alleviate fear an d
produce relaxation. Respiratory depression and not infrequently circulatory de~
press1on are not uncommon when these drugs are exhibited in an attempt to
attain rna,imum therapeutic effect and are a most dangerous symptom of opiate
intoxication. These deleterious effects have in many ins tances precl uded che1r
u~e in geriacr1c, pediatric and obstetric patients.

Demethylation of morphine, codeine and other related alkaloids diminishes th eir
analgesic potency. In 1915 Pohl' by substitution of an ally! for a methyl group in
codeine, produced a compound called 1 -allylnorcodeine that cou nteracted to some
extent the respiratory dcpres\ant effect of morphine. i\lcC:twley, H art and
\ 1ari..h 2 in 1941 substituted an ally! for a methyl group in morphine. This compound known a\ ~ -allylnormorphine was shown tO have marked stimulatory
effecti.. on respiration and circulation in animals depressed by morphine. In 1943
l nna 1 reported its use in antagoni1ing the effects of morphine injec ted into mice.
The data rernained in the literature as a pharmacological curiosity until 1952 wh en
1·.ckenhoff, Elder and King• reported the use of N-allylnormorphine in the treatment of morphine and demerol narcosis and overdose.
" -illl) lnormorp hine is stru rurally identica l with morp hine except for the replacement of a methyl group. ( Fig. I) i\ leperidine is structurally different from
morphine when the formula is ,Hitten on paper, and t he relationship between the
t\\O molecule.., i, obscure; but when t hree-dimensional models are constructed
there 1, a clo..,e \lmilarity of pauern, so we can expect N-allylnormorphine to
,rntagon11e meperidine. Recent clinical studies have shown N-a ll ylnormorphine
to he etfecr1,·e agam"lt clepres..,ion produced hr dilaudid, metapon, methadon,
morphine and meperitline.
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N-allylnormorphine is quite interesting. Injected intravenou.,ly into a normal
unpremedicated individual, it acts as a respiratory and circulatory depressant.
Evidence presented by Tenney et. al.Ii points ro the fact that N-allylnormorphine
changes the threshold response of the respiratory center to carbon dioxide tension
or pH. The sensitivity of the respiratory center is lowered by appro'ti1nately
50 percent.
\\'hen the drug is injected into man, prior to the administration of a large dose
of morphine, it inhibits the respiratory and circulatory depressant actions of the
opiate; injected into a patient narcotized from large doses of the opiate~, it causes
a strong respiratory stimulation as well as a moderate circulatory sti mulation.
In spite of the stimulatory actions following opiate depression N-allylnormorphine
seems to do little to counteract the sedation and analgesia produced by the opiates.
Injection of N-allylnormorphine into a subject deeply narcotized by morphine or
any of its derivatives produces a dramatic effect as far as respiratory ~timulation
1s concerned. The respiratory stim ulation when 5 mgm. of the drug is exhibited
intravenously in a patient narcotized with 60 mgm. of intravenous morphine is
.., triking. The deep slow respirations that characterize opiate poisoning abruptly
change after the antagonist is ex hibited . In 15 or 20 seconds respiratory rate is
increased 3-~ fold with regular less deep breathing. The change is not gradual
as one sees after picrotoxin antagonism of barbiturate intoxication, nor is it an
intense stimulation such as that seen with nikethamide or metrazol. Intense
, timulntion and then the gradu:11 decline in respirator)' rate and minute volume
1s not a characteristic of the new antagonist.
The effect of the antagonism on the circulation of the narcotized patient is
nor dramatic. If the blood pressure is depressed, it returns toward normal levels.
If the pressure is normal the drug causes no marked change. The pulst" rare is uniformly slowed.
The site of action of N-allylnormorphine has not been defined, but it is probably
central. It may ac t in a competitive fashion with the opiates for certain receptor~
on cells of the central nervous system. It is possible for the drug to either occupy rhe receptor and block the action of the opiate, or it may displace the opiate.
This is probably a nonspecific action because rhe sedative effect of the opiate is
not blocked or completely displaced.
Another drug capable of the same effecrs against some of the opiate~ is levallorphan tart rate (3- hydroxy-n-allyl-mo rphinan ). It bears a relationship ro clromoran similar to that ofN-allylnormorphine to morphine. It is an effective antagonist against respiratory depression produced by dromoran, nisentil, morphine, and
demerol. Here then, we have two drugs which can be used intravenously to
combat ro'tic effects of narcotics.
Some anesthetists have been usi ng these drug~ prophylaccically in an attempt tO
eliminate the respiratory depressant and hypotensive effect \ that intravenous
opia tes possess. Obstetricians arc using rhe drugs prior to delivery of an infonr
from a mother who is unduly depressed by opiates. 1 The respiratory <lepres~ion
in the newborn due to placental transfer of opiates is prevented by the antagonists.
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The drug may abo be given in 2 mgm. doses directl)r into the infant's umbilical
vcan if the depression of the newborn is thought t0 be due to opiates.
ed this
v.ay rhe analcptic effect is quite dramatic.
It is important to remember that these drugs have no effect on depression of
circulation or respiration caused by the barbiturates or any of the anesthetic
agents. They are specific antagonists of opiates. 1 .allyl normorphine or leval.
!orphan in persons not under the influence of narcotics produces lethargy, mild
drowsincsi,, vivid daydreams, and dysphoria varying in intensity from vague
anxiety to acute panic. All subjects complained of inability to repress such daydreami,.
Of course, it goes without saying that these two drugs are life saving in the
pre. ence of severe opiate overdose, be it self-induced or accidental. The drugs are
specific and are u~ed in a 10 mgm. dose intravenously after the usual clear airway
and adequate oxygenation of the patient is obtained. Repeated injections of the
drug every 4-5 minutes, until 60 mgm. or more have been given, may be required
to effect a . timulation of respiration and circulation in a severely poisoned indindual.
It would~ interesting to know what specific structural unit of N-allylnormorphine ;.m<l le\"allorphan causes the antagonism of the opia tes. If such a unit 1s
found the chemists might be able to synthesize drugs which could have the same
effect of antagonizing the respiratory depressant effects of barbiturates or cyclopropane.
Progre,s i\ being made in this direction. A wide number of drugs have been reported to have analeptic properties against rhe opiares. All of these analepric
drug, have either a muscarine like action or are anti-choline esterase drugs. -\
common chemical link in all of these drugs is a 2-4 diamino 5 phenyl thiazole.
\\"hen drug "ith this linkage were rried against barbiturate intoxicated dog-.
the,- \\ere rou ed. ..\ report of successful trials in animals and in 20 cases of barhiturate po1"i0ning in man of a new drug incorporating the 2-4 diamino 5 phenyl
chia,ole linkage ha, recent!)' been made. This may be the linkage which is common
ro analcptic of rhis type. It will be interesting to see if the speci fic structural
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unit can be isolated and u,;;ed successfully. The barbiturate antagonist increased
respiration and as the dose was increased produced wakening. If the drug is used
in normal subjects it produces convulsions which can be controlled with barbiturates. The new drug ( Fig. 2) is designated NP 13. Chemically it is bb methyl
ethyl glutarimide and is quite specific against barbiturates.
The opiate antagonists are proving their usefulness everyday. Barbiturate
antagonists with as much specificity as N-allylnorm orphine would be a great advance in treatment of barbiturate toxicity.
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